HHS releases COVID-19 monoclonal antibody to treat
Post# of 148106
"commercially procured bebtelovimab, a COVID-19 monoclonal antibody therapy for outpatients at high risk for hospitalization
https://www.aha.org/news/headline/2022-09-26-...newsletter
bebtelovimab
https://www.google.com/search?q=bebtelovimab&...p;ie=UTF-8